Longboard Pharmaceuticals, Inc. Accrued Liabilities, Current
Longboard Pharmaceuticals, Inc. had Accrued Liabilities, Current of $1.89 million as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2024-11-07
- 2024-09-30: Accrued Liabilities, Current $1.89M.
- 2024-06-30: Accrued Liabilities, Current $551.00K.
- 2024-03-31: Accrued Liabilities, Current $572.00K.
- 2023-12-31: Accrued Liabilities, Current $368.00K.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2024-09-30 | $1.89M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $551.00K 10-Q · filed 2024-08-01 |
| 2024-03-31 | $572.00K 10-Q · filed 2024-05-02 |
| 2023-12-31 | $368.00K 10-Q · filed 2024-11-07 |
| 2023-09-30 | $484.00K 10-Q · filed 2023-11-02 |
| 2023-06-30 | $559.00K 10-Q · filed 2023-08-03 |
| 2023-03-31 | $1.07M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $490.00K 10-K · filed 2024-03-12 |
| 2022-09-30 | $829.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $1.34M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $1.54M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $352.00K 10-K · filed 2023-03-02 |
| 2021-09-30 | $231.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $162.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $699.00K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $845.00K 10-K · filed 2022-03-03 |